Tirzepatide
Tirzepatide is a 39-amino-acid dual agonist of GIP and GLP-1 receptors. Supplied as a sterile-filtered lyophilized powder for investigational research.
$150
10mg vial
Molecular weight
4813.45 g/mol
Form
Lyophilized powder
Quantity
10mg vial
Category
Metabolic
Research profile
Ships in 2–3 business days · For research use only
What researchers are studying
In the published literature.
Research literature explores the combined incretin mechanism of tirzepatide, including effects on insulin sensitivity biomarkers and appetite-related neuronal circuits in preclinical models.
- PMID
Tirzepatide Once Weekly for the Treatment of Obesity
Jastreboff AM et al., NEJM, 2022
View on PubMed →
Research framing. The summaries above describe the published literature. Verdaine does not make medical claims and does not recommend human consumption. These products are intended solely for in vitro research and laboratory investigation.